Taimei Technology

Taimei Technology (Zhejiang Taimei Medical Technology Co., Ltd) is a digital intelligence platform for the life sciences industry, specializing in pharmaceutical R&D, drug safety, and medical marketing. The company builds collaborative digital infrastructure that connects all key stakeholders — pharmaceutical companies, hospitals, CROs, SMOs, doctors, and patients — leveraging AI, big data, and cloud computing to streamline processes, enable seamless data flow, and enhance collaboration. Driven by the mission to "Harness Digital Power to Make Health Accessible," Taimei works to accelerate drug approvals, improve medication safety, increase access to effective treatments, and reduce patient costs.

Taimei serves a broad and growing ecosystem, with over 1,400 pharmaceutical companies and CROs using its products and services, approximately 700 national clinical trial institutions partnered with the platform, more than 370 SMOs engaged as partners, and a team of approximately 800 cross-disciplinary pharma and IT experts. The company offers more than 40 software products and digital services, and listed on the Hong Kong Stock Exchange (HKEX) on October 8, 2024.

Clinical Data Management Solutions

• eCollect (EDC): Electronic data capture solution for clinical trial data collection and management.
• eBalance (RTSM): Real-time subject and medication management platform supporting randomization and trial supply management.
• eCOA: Electronic clinical outcome assessment tool for capturing patient-reported and clinician-reported outcomes.

Clinical Operations Solutions

• CTMS: Clinical Trial Management System for managing and monitoring clinical research projects, supporting multi-dimensional process management and real-time visualization of site and project data.
• eTMF: Electronic Trial Master File solution for managing and archiving essential clinical trial documents.

R&D Digital Solutions

• Digital solution for enterprise clinical research, supporting large pharmaceutical companies in managing complex, multi-site studies.
• Digital solution for hospital-based clinical research, enabling research institutions to manage investigator-initiated and sponsored trials.
• Digital solution for clinical research service providers, including CROs and SMOs.
• Digital solution for regional clinical research management, supporting coordinated oversight across geographies.
• Innovative digital solution for Decentralized Clinical Trials (DCT), enabling remote and patient-centric trial models.

Pharmacovigilance Solutions

• Digital solution for clinical research safety information management, including the eSAE and eSafety products.
• Digital solution for post-market pharmacovigilance, supporting ongoing drug safety monitoring after approval.
• Comprehensive pharmacovigilance solution covering the full drug lifecycle, from clinical development through commercialization.

Marketing Digital Solutions

• Multi-channel digital marketing solution for pharmaceuticals, enabling targeted engagement across diverse channels.
• Pharmaceutical marketing data platform, providing centralized data infrastructure to support data-driven commercial strategies.

Platform Offerings

• TrialOS Pharmaceutical R&D Collaboration Platform: A unified login portal connecting pharmaceutical companies, hospitals, third-party providers, patients, and regulatory agencies. TrialOS standardizes processes, enables data flow, breaks data silos, fosters collaboration, integrates resources, and boosts overall efficiency in clinical research.
• PharmaOS Digital Marketing Platform: Integrates an omnichannel marketing system with a centralized marketing data platform to break data silos and deliver end-to-end, data-driven digital marketing solutions. Enables comprehensive targeting of key customers, refined sales management, precise decision-making, and improved business performance.

Compliance and Certifications

• Compliant with international standards including Title 21 CFR Part 11, ICH-E2B, GAMP5, and CDISC.
• Information System Security Level Protection (Level 3) certification under national standards.
• Certified under six international ISO standards: ISO 20000 (IT Service Management), ISO 9001 (Quality Management System), ISO 27001 (Information Security Management System), ISO 27701 (Privacy Information Management System), and ISO 27018 (Protection of personally identifiable information in cloud storage).

Company History and Growth

• 2013: Founded with angel investment from Kaifeng Ventures and Series A funding from Matrix Partners China; launched core products including eCollect, eCooperate, eReport, eBalance, and eSafety; provided data management and statistical analysis services.
• 2016: Raised Series B, C, and D funding from investors including Northern Light Venture Capital, Loyal Valley Capital, Morningside Venture Capital, SAIF Partners, SoftBank China, and others; expanded into pharmacovigilance, imaging evaluation, and the hospital sector; released eCollege, eImage, eTrial, and eSite.
• 2019: Raised Series E (led by Tencent) and Series F (led by Tencent, Hillhouse Capital, and Yunfeng Fund) totaling nearly RMB 2 billion; launched the TrialOS platform; acquired Softstone Technology to expand into digital marketing; established Shengfang Pharmaceutical R&D for CRO services; introduced digital SMO services; launched eSAE, eScreening, GCP-X, iRMS, and the ONE marketing product series.
• 2022 onward: Established international branches in the U.S. and Singapore; launched eSAE, TrialPro, and IDS; released international versions of eCollect, eBalance, Paylite, eCooperate, and eArchives.
• October 2024: Listed on the Hong Kong Stock Exchange (HKEX).

With a comprehensive suite of over 40 software products and digital services spanning clinical data management, clinical operations, pharmacovigilance, and pharmaceutical marketing, Taimei Technology is building the digital infrastructure needed to transform the life sciences industry and make quality medicines more accessible to patients worldwide.